Various clinical trials have evaluated the clinical value of an initial dose intensification of imatinib in CML-CP patients (an overview of the most important response rates is given in Table 1).
Imkeldi is a new formulation of imatinib approved as a strawberry-flavored, shelf-stable liquid designed to be more appealing ...
In 2001, a Time Magazine cover story touted Novartis’ targeted leukemia treatment Gleevec (imatinib) as a new kind of ...
The oral solution offers precise dosing, benefiting patients with swallowing difficulties or requiring tailored dosing.
Imatinib oral solution has gained FDA approval for the treatment of some cancers, including certain forms of leukemia.
Imkeldi is a liquid formulation of imatinib that utilizes proprietary technology to allow for accurate dosing and an alternative formulation to tablets.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback